EGFR and cancer: Activating EGFR mutations could transcriptionally increase CD47 expression via the activation of ERK/c‐Myc and AKT/NF‐κB signaling, which impairs macrophage phagocytosis and mediates innate immune evasion of cancer cells.[251]